Repository logo

Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis

dc.contributor.authorDave, Chintan
dc.contributor.authorMcRae, Andrea
dc.contributor.authorDoxtator, Emily
dc.contributor.authorMei, Shirley H J
dc.contributor.authorSullivan, Katrina
dc.contributor.authorWolfe, Dianna
dc.contributor.authorChampagne, Josee
dc.contributor.authorMcIntyre, Lauralyn
dc.date.accessioned2020-08-25T03:40:34Z
dc.date.available2020-08-25T03:40:34Z
dc.date.issued2020-08-19
dc.date.updated2020-08-25T03:40:34Z
dc.description.abstractAbstract Background Mesenchymal stem cells (MSCs) are multipotent cells that demonstrate therapeutic potential for the treatment of acute and chronic inflammatory-mediated conditions. Especially for acute conditions, it is critical to have a readily available freshly thawed (cryopreserved) MSC product for rapid administration. Although controversial, some studies suggest that MSCs may lose their functionality with cryopreservation which in turn could render them non-efficacious. Objective In controlled preclinical in vivo models of inflammation, to determine if there are differences in surrogate measures of preclinical efficacy between freshly cultured and freshly thawed MSCs Methods/design A systematic search for pre-clinical in vivo inflammatory model studies will compare freshly cultured to freshly thawed MSCs from any source. The primary outcomes will include measures of in vivo preclinical efficacy; secondary outcomes will include measures of in vitro MSC potency. Electronic searches for MEDLINE and EMBASE will be constructed and reviewed by the Peer Review of Electronic Search Strategies (PRESS) process. If applicable, study outcomes will be meta-analyzed using a random effects model. Risk of bias will be assessed by the SYRCLE “Risk of Bias” assessment tool for preclinical in vivo studies. Discussion The results of this systematic review will provide translational scientists, clinical trialists, health regulators, and the clinical and public community with the current pre-clinical evidence base related to the efficacy and potency of freshly cultured versus freshly thawed MSCs, help identify evidence gaps, and guide future related research. Systematic review registration Protocol is submitted to PROSPERO for registration (pending confirmation) and will be submitted to Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADES) for public posting.
dc.identifier.citationSystematic Reviews. 2020 Aug 19;9(1):188
dc.identifier.urihttps://doi.org/10.1186/s13643-020-01437-z
dc.identifier.urihttps://doi.org/10.20381/ruor-25098
dc.identifier.urihttp://hdl.handle.net/10393/40872
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleComparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
13643_2020_Article_1437.pdf
Size:
536.44 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: